funding Archives - Page 2 of 3

Business People: Mitch Abrahamsen

Business People: Mitch AbrahamsenIT ADMIN2020-08-14T16:47:59-05:00

People On the Move: Mitchell Abrahamsen

People On the Move: Mitchell AbrahamsenIT ADMIN2017-07-11T15:45:42-05:00

RCI Names Dr. Mitchell Abrahamsen as EVP & CCO

Recombinetics (RCI) announced that Dr. Mitchell Abrahamsen has joined RCI as Executive Vice President and Chief Commercial Officer. Dr. Abrahamsen will lead product and business development efforts for RCI and its subsidiaries that are commercializing gene-edited animal models for biomedical and agricultural use, Acceligen and Surrogen. Abrahamsen will also continue to [...]

RCI Names Dr. Mitchell Abrahamsen as EVP & CCOIT ADMIN2017-07-07T14:07:48-05:00

Gene Editing Market to Observe High Growth by 2017 – 2025

Gene Editing Market to Observe High Growth by 2017 – 2025Adam Davies2020-08-14T16:48:58-05:00

Modernization of Healthcare Services to Propel Gene Editing Market

Modernization of Healthcare Services to Propel Gene Editing MarketAdam Davies2020-08-14T16:49:24-05:00

Recombinetics Raises $7M, Hints at Bigger Funding Efforts Ahead

Recombinetics Raises $7M, Hints at Bigger Funding Efforts AheadAdam Davies2020-08-14T16:50:50-05:00

Below the radar, Minnesota bio firms bloom

Below the radar, Minnesota bio firms bloomIT ADMIN2020-08-14T17:06:38-05:00

Recombinetics Raises $11M In Oversubscribed Investment Round

Recombinetics Raises $11M In Oversubscribed Investment RoundIT ADMIN2020-08-14T17:08:52-05:00

Recombinetics Raises $11 Million As It Heads Toward Commercialization

Recombinetics Raises $11 Million As It Heads Toward CommercializationIT ADMIN2020-08-14T17:09:35-05:00

Recombinetics Closes on $11M in Funding

Recombinetics Closes on $11M in FundingIT ADMIN2020-08-14T17:10:09-05:00